ThermoGenesis Holdings, Inc. financial data

Symbol
THMO on OTC
Industry
Laboratory Apparatus & Furniture
Location
2890 Kilgore Rd., Rancho Cordova, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
CESCA THERAPEUTICS INC. (to 10/31/2019), THERMOGENESIS CORP (to 2/19/2014), THERM0GENESIS CORP (to 11/3/1995)
Latest financial report
10-Q - Q1 2024 - May 17, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 62.4 % -40.6%
Quick Ratio 17.9 % -54.6%
Debt-to-equity 693 % +140%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.95M shares +418%
Common Stock, Shares, Outstanding 7.95M shares +418%
Entity Public Float 2.83M USD -33.9%
Common Stock, Value, Issued 8K USD +300%
Weighted Average Number of Shares Outstanding, Basic 4.03M shares +222%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.19M USD -21.2%
Operating Income (Loss) -8.12M USD -34.7%
Earnings Per Share, Basic -3.98 USD/shares +77.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.18M USD -79.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1.15M USD +20.3%
Inventory, Net 1.25M USD -63.6%
Assets, Current 4.35M USD -60.3%
Property, Plant and Equipment, Net 2.47M USD +28.1%
Operating Lease, Right-of-Use Asset 50K USD -84.1%
Intangible Assets, Net (Excluding Goodwill) 1.26M USD -2.47%
Goodwill 781K USD 0%
Other Assets, Noncurrent 256K USD 0%
Assets 10.1M USD -48.9%
Accounts Payable, Current 988K USD +5.78%
Employee-related Liabilities, Current 398K USD -10.6%
Contract with Customer, Liability, Current 921K USD +26.3%
Liabilities, Current 8.3M USD -20.7%
Contract with Customer, Liability, Noncurrent 122K USD -85.4%
Operating Lease, Liability, Noncurrent 2.72M USD +4937%
Other Liabilities, Noncurrent 28K USD +55.6%
Liabilities 11.2M USD -24.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 114K USD +8.57%
Retained Earnings (Accumulated Deficit) -286M USD -5.44%
Stockholders' Equity Attributable to Parent 975K USD -84%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.09M USD -122%
Liabilities and Equity 10.1M USD -48.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -505K USD +17.9%
Net Cash Provided by (Used in) Financing Activities -299K USD -110%
Net Cash Provided by (Used in) Investing Activities -20K USD +97.4%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 7.95M shares +418%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -824K USD -149%
Interest Paid, Excluding Capitalized Interest, Operating Activities 102K USD -27.1%
Deferred Tax Assets, Valuation Allowance 34.5M USD +12.3%
Deferred Tax Assets, Gross 35.4M USD +11.3%
Operating Lease, Liability 3.36M USD
Payments to Acquire Property, Plant, and Equipment 20K USD -97.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.7M USD -2.43%
Lessee, Operating Lease, Liability, to be Paid 4.9M USD
Property, Plant and Equipment, Gross 10.2M USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.43M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.36M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.22 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.54M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD
Deferred Tax Assets, Operating Loss Carryforwards 29.2M USD +10.5%
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 287M USD +3.47%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 334K USD +25.1%
Interest Expense 7.58M USD -12.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%